NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 55 min ago

Notice of Information: NIAAA Clinical Medications Development Testing Program

Wed, 2021-03-24 11:47
Notice NOT-AA-21-008 from the NIH Guide for Grants and Contracts

Updated Notice of Limited Availability of Research Non-Human Primates

Wed, 2021-03-24 05:55
Notice NOT-OD-21-080 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards

Tue, 2021-03-23 13:52
Notice NOT-TW-21-003 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Characterization of Genomics of Induced Pluripotent Stem Cell Lines for AD/ADRD Research

Tue, 2021-03-23 13:47
Notice NOT-NS-21-041 from the NIH Guide for Grants and Contracts

Updated Reporting Requirements for RADx-rad Grant Recipients

Tue, 2021-03-23 13:25
Notice NOT-OD-21-084 from the NIH Guide for Grants and Contracts

Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed)

Tue, 2021-03-23 12:05
Funding Opportunity RFA-AG-22-009 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support short courses geared towards advancing selected priority topic areas identified by the National Institute on Aging (NIA) in order to advance research in the behavioral and social sciences. This FOA targets the following three priority research areas: 1) genomics for social scientists; 2) interdisciplinary social science research in aging; and 3) reproducibility in the social and behavioral sciences.

Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed)

Tue, 2021-03-23 12:05
Funding Opportunity RFA-AG-22-010 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support short courses geared towards advancing selected priority topic areas identified by the National Institute on Aging in order to advance behavioral and social science research on Alzheimer's disease and its related dementias (AD/ADRD). This FOA targets the following three priority research areas: 1) cross-national dementia research using harmonized data on cognitive function; 2) behavioral economic approaches to improve AD/ADRD health care delivery at the organizational level; and 3) integrating machine learning and the social sciences to improve healthcare research in AD/ADRD.

Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)

Tue, 2021-03-23 04:22
Funding Opportunity RFA-AT-21-006 from the NIH Guide for Grants and Contracts. This proposed initiative aims to solicit applications that focus on developing resources by refining and testing key concepts that will advance and further support the study of the neurocircuitry of force-based manipulations. This grant funding initiative will support research networks through meetings, conferences, small-scale pilot research, multidisciplinary cross training (such as intensive workshops, summer institutes, or visiting scholar programs), and information dissemination to foster the growth and development of research in the specified priority areas listed below.

Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)

Tue, 2021-03-23 03:57
Funding Opportunity PAR-21-183 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer unprecedented opportunities to develop clinical-grade mobile, web, or other software-based platforms designed to deliver treatments that are safe and effective for SUD. FDA authorization of DTx can play an important role in increasing the availability of treatments to patients with SUD, although there are other pathways for dissemination of this class of intervention. The primary objective of this FOA is to move DTx to their next step in the development process, with the ultimate goal of generating new, FDA authorized, disseminated treatments for SUDs. Applications may focus on the pre-clinical and/or clinical development and testing of new DTx or existing DTx developed for other indications.

Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies

Tue, 2021-03-23 03:37
Notice NOT-AI-21-032 from the NIH Guide for Grants and Contracts

Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)

Tue, 2021-03-23 03:36
Funding Opportunity RFA-MD-21-004 from the NIH Guide for Grants and Contracts. This initiative will support (1) observational research to understand the role of structural racism and discrimination (SRD) in causing and sustaining health disparities, and (2) intervention research that addresses SRD in order to improve minority health or reduce health disparities.

Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed)

Tue, 2021-03-23 03:14
Funding Opportunity PAR-21-212 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications specific to sample acquisition, genome wide association studies, whole genome sequencing, quality control checking, variant calling, data calling, data sharing, data harmonization, and analysis that will support the generation of data from multi-ethnic cohorts for the Alzheimer's Disease Sequencing Project Follow-Up Study 2.0: The Diverse Population Initiative.

Continued Extension of Certain Flexibilities for Prospective Basic Experimental Studies With Human Participants

Tue, 2021-03-23 02:35
Notice NOT-OD-21-088 from the NIH Guide for Grants and Contracts

Pages